This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Are Conglomerates Stocks Lagging Carlisle Companies (CSL) This Year?
by Zacks Equity Research
Here is how Carlisle (CSL) and Griffon (GFF) have performed compared to their sector so far this year.
Carlisle (CSL) Crossed Above the 20-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?
Reasons Why You Should Avoid Betting on GE Aerospace (GE)
by Zacks Equity Research
Increasing costs and unfavorable foreign-currency movement weigh on GE Aerospace's (GE) operations.
Zacks Industry Outlook Highlights Carlisle, Griffon and ITT
by Zacks Equity Research
Carlisle, Griffon and ITT are part of the Zacks Industry Outlook article.
Zacks.com featured highlights include Carlisle Companies, ResMed, Booz Allen Hamilton and CrediCorp
by Zacks Equity Research
Carlisle Companies, ResMed, Booz Allen Hamilton and CrediCorp are part of the Zacks Screen of the Week article.
Scoop up These 4 GARP Stocks to Receive Handsome Returns
by Zacks Equity Research
The GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount. CSL, RMD, BAH and BAP are some stocks that hold promise.
3 Diversified Operations Stocks to Overcome Industry Headwinds
by Avisekh Bhattacharjee
Weakness in the manufacturing sector and supply chain issues dampen the prospects of the Zacks Diversified Operations industry. CSL, GFF and ITT are notable stocks in the industry.
Carlisle (CSL) Divests Interconnect Technologies Business
by Zacks Equity Research
Carlisle (CSL) divests the CIT segment to direct its focus to its core business and portfolio enhancement efforts.
Are You Looking for a Top Momentum Pick? Why Carlisle (CSL) is a Great Choice
by Zacks Equity Research
Does Carlisle (CSL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Honeywell (HON) Rides on Business Strength Amid Headwinds
by Zacks Equity Research
Honeywell (HON) gains from strength in its Aerospace segment, buyouts and shareholder-friendly policies. Softness in the warehouse and workflow solutions unit remains concerning.
Danaher (DHR) Rides on Business Strength Amid Headwinds
by Zacks Equity Research
Danaher (DHR) gains from strength in academic and applied markets, Abcam buyout and pro-investor policies. However, softness in its Biotechnology unit is concerning.
ITT Q1 Earnings & Revenues Beat Estimates, Increase Y/Y
by Zacks Equity Research
ITT's Q1 revenues increase 14.1% year over year, driven by higher friction original equipment volumes in the Motion Technologies unit and volume growth in aerospace and defense components.
3M (MMM) Q1 Earnings & Revenues Surpass Estimates, Up Y/Y
by Zacks Equity Research
3M (MMM) reports first-quarter 2024 results, wherein adjusted revenues inch up 0.5% year over year.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Carlisle Companies Incorporated (CSL) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Carlisle (CSL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Beat the Market the Zacks Way: ADMA Biologics, Carlisle, McCormick Manufacturing in Focus
by Santanu Roy
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Carlisle (CSL) Q1 Earnings & Revenues Beat Estimates, Up Y/Y
by Zacks Equity Research
Carlisle (CSL) first-quarter 2024 results benefit from higher revenues across the Carlisle Construction Materials segment.
Carlisle (CSL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Carlisle (CSL) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Should You Invest in the Invesco Building & Construction ETF (PKB)?
by Zacks Equity Research
Sector ETF report for PKB
GE Aerospace (GE) Q1 Earnings Surpass Estimates, Up Y/Y
by Zacks Equity Research
GE Aerospace (GE) first-quarter 2024 results reflect 11% increase in revenues, driven by solid performance from its Aerospace segment.
Danaher (DHR) Q1 Earnings Beat, Biotechnology Sales Dip Y/Y
by Zacks Equity Research
While Danaher (DHR) surpasses first-quarter earnings and revenue estimates, its performance is hurt by a decrease in core sales in the Biotechnology segment.
Analysts Estimate LSB (LXU) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
LSB (LXU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Insights Into Carlisle (CSL) Q1: Wall Street Projections for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Carlisle (CSL), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.
Here's Why Carlisle (CSL) Fell More Than Broader Market
by Zacks Equity Research
Carlisle (CSL) closed at $367.41 in the latest trading session, marking a -0.39% move from the prior day.
Danaher (DHR) Gears Up to Post Q1 Earnings: Is a Beat Likely?
by Zacks Equity Research
Danaher's (DHR) Q1 earnings are likely to be hurt by weakness in the Biotechnology unit. Improving supply chains and strong price realization are expected to be positives.